ATE195124T1 - Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren - Google Patents
Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzierenInfo
- Publication number
- ATE195124T1 ATE195124T1 AT97914792T AT97914792T ATE195124T1 AT E195124 T1 ATE195124 T1 AT E195124T1 AT 97914792 T AT97914792 T AT 97914792T AT 97914792 T AT97914792 T AT 97914792T AT E195124 T1 ATE195124 T1 AT E195124T1
- Authority
- AT
- Austria
- Prior art keywords
- carbazole
- potentiate
- activity
- gamma interferon
- pyrrolo
- Prior art date
Links
- 102000008070 Interferon-gamma Human genes 0.000 title 1
- 108010074328 Interferon-gamma Proteins 0.000 title 1
- VHLKRJCSUDZZTF-UHFFFAOYSA-N carbazol-3-one Chemical compound C1=CC=C2C3=CC(=O)C=CC3=NC2=C1 VHLKRJCSUDZZTF-UHFFFAOYSA-N 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 229940044627 gamma-interferon Drugs 0.000 title 1
- 230000003389 potentiating effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/604,474 US5616724A (en) | 1996-02-21 | 1996-02-21 | Fused pyrrolo[2,3-c]carbazole-6-ones |
| PCT/US1997/002905 WO1997031002A1 (en) | 1996-02-21 | 1997-02-20 | Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE195124T1 true ATE195124T1 (de) | 2000-08-15 |
Family
ID=24419747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97914792T ATE195124T1 (de) | 1996-02-21 | 1997-02-20 | Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5616724A (de) |
| EP (1) | EP0885229B1 (de) |
| JP (1) | JP2000505458A (de) |
| KR (1) | KR19990087074A (de) |
| CN (1) | CN1098266C (de) |
| AT (1) | ATE195124T1 (de) |
| AU (1) | AU716265B2 (de) |
| BR (1) | BR9707659A (de) |
| DE (1) | DE69702705T2 (de) |
| DK (1) | DK0885229T3 (de) |
| ES (1) | ES2150233T3 (de) |
| GR (1) | GR3034533T3 (de) |
| NZ (1) | NZ330837A (de) |
| PT (1) | PT885229E (de) |
| RU (1) | RU2193037C2 (de) |
| WO (1) | WO1997031002A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US6127401A (en) | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
| US6200968B1 (en) | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| CN1329034C (zh) | 1998-09-25 | 2007-08-01 | 赛福伦公司 | 预防/治疗感觉毛细胞和耳蜗神经元损伤的药物 |
| US6656474B1 (en) * | 1999-01-15 | 2003-12-02 | Regeneron Pharmaceuticals, Inc. | Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders |
| US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| US6399780B1 (en) | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
| FR2798931B1 (fr) * | 1999-09-22 | 2001-11-16 | Oreal | Nouveaux composes indoliques, leur utilisation pour la teinture et le maquillage des matieres keratiniques, compositions les contenant et procedes de teinture |
| EP1274720A4 (de) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | Albumin enthaltende fusionsproteine |
| US6630500B2 (en) | 2000-08-25 | 2003-10-07 | Cephalon, Inc. | Selected fused pyrrolocarbazoles |
| AR035971A1 (es) * | 2001-05-16 | 2004-07-28 | Cephalon Inc | Metodos para el tratamiento y la prevencion del dolor |
| PT1463751E (pt) | 2001-12-21 | 2013-08-26 | Human Genome Sciences Inc | Proteínas de fusão de albumina |
| CA2513213C (en) | 2003-01-22 | 2013-07-30 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7169802B2 (en) * | 2003-12-23 | 2007-01-30 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| US20060134175A1 (en) * | 2004-12-22 | 2006-06-22 | Stephen Bartels | Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use |
| US20060134176A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
| US20060134174A1 (en) * | 2004-12-22 | 2006-06-22 | Bausch & Lomb Incorporated | Pharmaceutical delivery system and method of use |
| WO2007002670A2 (en) * | 2005-06-28 | 2007-01-04 | Bausch & Lomb Incorporated | Method of lowering intraocular pressure |
| US20090155352A1 (en) * | 2007-11-20 | 2009-06-18 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
| WO2010059795A1 (en) * | 2008-11-19 | 2010-05-27 | Cephalon, Inc. | Novel forms of an indazolo [5,4-a] pyrrolo [3,4-c] carbazole compound |
| EP2192121A1 (de) | 2008-11-27 | 2010-06-02 | Cephalon France | Regioselektive Reduktion von fusionierten Pyrrolocarbazol-5,7-Dionen |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552842A (en) * | 1983-01-28 | 1985-11-12 | Bristol-Myers Company | Process for producing rebeccamycin |
| US4923986A (en) * | 1987-03-09 | 1990-05-08 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of physiologically active substance K-252 |
| DE3803620A1 (de) * | 1988-02-06 | 1989-08-17 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und diese enthaltende arzneimittel |
| DE3835842A1 (de) * | 1988-10-21 | 1990-04-26 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| SK75289A3 (en) * | 1988-02-10 | 1998-05-06 | Hoffmann La Roche | Substituted pyrroles, their use for producing a drug, and the drug on their base |
| DE3833008A1 (de) * | 1988-09-29 | 1990-04-05 | Goedecke Ag | Pyrrolocarbozol-derivate, verfahren zu deren herstellung und deren verwendung als arzneimittel |
| MC2096A1 (fr) * | 1989-02-23 | 1991-02-15 | Hoffmann La Roche | Pyrroles substitues |
| DE69013011T2 (de) * | 1989-12-20 | 1995-02-23 | Schering Corp., Kenilworth, N.J. | Bcrf1-proteine als inhibitoren von interferon-g(g). |
| DE3942296A1 (de) * | 1989-12-21 | 1991-06-27 | Goedecke Ag | Indolocarbazol-derivate, verfahren zu deren herstellung und deren verwendung |
| US5185260A (en) * | 1991-08-29 | 1993-02-09 | The United States Of America As Represented By The United States Department Of Energy | Method for distinguishing normal and transformed cells using G1 kinase inhibitors |
| NZ245203A (en) * | 1991-11-29 | 1997-07-27 | Banyu Pharma Co Ltd | 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates |
| US6271242B1 (en) * | 1992-02-10 | 2001-08-07 | Bristol-Myers Squibb Co. | Method for treating cancer using a tyrosine protein kinase inhibitor |
| US5405864A (en) * | 1993-10-15 | 1995-04-11 | Syntex (U.S.A.) Inc. | Chemotherapeutic maleimides |
-
1996
- 1996-02-21 US US08/604,474 patent/US5616724A/en not_active Expired - Lifetime
-
1997
- 1997-02-20 DK DK97914792T patent/DK0885229T3/da active
- 1997-02-20 WO PCT/US1997/002905 patent/WO1997031002A1/en not_active Ceased
- 1997-02-20 KR KR1019980706460A patent/KR19990087074A/ko not_active Ceased
- 1997-02-20 DE DE69702705T patent/DE69702705T2/de not_active Expired - Fee Related
- 1997-02-20 NZ NZ330837A patent/NZ330837A/xx unknown
- 1997-02-20 RU RU98117389/04A patent/RU2193037C2/ru active
- 1997-02-20 JP JP9530385A patent/JP2000505458A/ja not_active Ceased
- 1997-02-20 AT AT97914792T patent/ATE195124T1/de not_active IP Right Cessation
- 1997-02-20 BR BR9707659A patent/BR9707659A/pt not_active Application Discontinuation
- 1997-02-20 CN CN97192377A patent/CN1098266C/zh not_active Expired - Fee Related
- 1997-02-20 ES ES97914792T patent/ES2150233T3/es not_active Expired - Lifetime
- 1997-02-20 PT PT97914792T patent/PT885229E/pt unknown
- 1997-02-20 AU AU21914/97A patent/AU716265B2/en not_active Ceased
- 1997-02-20 EP EP97914792A patent/EP0885229B1/de not_active Expired - Lifetime
- 1997-03-28 US US08/827,215 patent/US5801190A/en not_active Expired - Fee Related
-
2000
- 2000-10-02 GR GR20000402223T patent/GR3034533T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2150233T3 (es) | 2000-11-16 |
| EP0885229B1 (de) | 2000-08-02 |
| GR3034533T3 (en) | 2001-01-31 |
| BR9707659A (pt) | 1999-04-13 |
| NZ330837A (en) | 1999-03-29 |
| DE69702705T2 (de) | 2001-04-05 |
| JP2000505458A (ja) | 2000-05-09 |
| EP0885229A1 (de) | 1998-12-23 |
| HK1017673A1 (en) | 1999-11-26 |
| AU716265B2 (en) | 2000-02-24 |
| AU2191497A (en) | 1997-09-10 |
| PT885229E (pt) | 2000-12-29 |
| DK0885229T3 (da) | 2000-10-16 |
| CN1211254A (zh) | 1999-03-17 |
| RU2193037C2 (ru) | 2002-11-20 |
| US5616724A (en) | 1997-04-01 |
| KR19990087074A (ko) | 1999-12-15 |
| US5801190A (en) | 1998-09-01 |
| CN1098266C (zh) | 2003-01-08 |
| DE69702705D1 (de) | 2000-09-07 |
| WO1997031002A1 (en) | 1997-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69702705D1 (de) | Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren | |
| ID23374A (id) | Halogenopirimidin | |
| DE69516847D1 (de) | Chlorpyrimidine als zwischenprodukte | |
| BG101132A (en) | Pyridoanilated thienyl and furanyl oxazolidinons | |
| BG101748A (en) | Heterocyclic condensated pyridines | |
| DK0751959T3 (da) | Modificerede polypeptider med forøget biologisk aktivitet | |
| DE69807074D1 (de) | Substituierte 1,2,4-triazolo[3,4,-a]phthalazin-derivate als gaba-alpha 5-liganden | |
| EP0695171A1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
| ATE259828T1 (de) | Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel | |
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| DE69710490D1 (de) | Triazolo(4,5-d)pyrimidinyl-derivate und ihre verwendung als medikamente | |
| PT934325E (pt) | Trisanidridos biciclicos de tetrafosfonato | |
| PT1017659E (pt) | Tetra-hidronaftalenos substituidos e compostos analogos | |
| ATE396205T1 (de) | Die verwendung von peptiden von il-2 und peptid- derivaten als therapeutische wirkstoffe | |
| FR2662698B1 (de) | ||
| FI891713L (fi) | Slangskal, speciellt konstgjort korvskal med limband i laengsaxelriktningen. | |
| BR0115121A (pt) | Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas | |
| YU12397A (en) | NOVEL PYRIMIDO [1,2-a] INDOLES | |
| GB9807114D0 (en) | Novel process | |
| PT633928E (pt) | Microrganismos processo de preparacao e utilizacao | |
| AP9901529A0 (en) | Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them. | |
| ZA983231B (en) | Substituted benzyloxyimino compounds. | |
| CA2241852A1 (en) | Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon | |
| BR9407232A (pt) | Compostos de tiocarbamoíla | |
| MX9302761A (es) | Metodo de sintesis de monomeros de nucleotido. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |